Tag | Content |
---|
EnhancerAtlas ID | HS195-04391 |
Organism | Homo sapiens |
Tissue/cell | VCaP |
Coordinate | chr21:36328610-36330640 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXA1 | MA0148.4 | chr21:36328838-36328854 | TTTTGTTTACACAGTG | - | 6.69 | ZNF263 | MA0528.1 | chr21:36329052-36329073 | CCATCCTGCTCGTTCTCCTCC | - | 6.14 | ZNF263 | MA0528.1 | chr21:36329064-36329085 | TTCTCCTCCTCTTCCTCTTTT | - | 6.5 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_09308 | chr21:36328458-36330523 | CD14 | SE_25349 | chr21:36325976-36330763 | DND41 | SE_39356 | chr21:36326141-36330722 | Jurkat | SE_66240 | chr21:36326141-36330722 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I034952 | chr21 | 36324728 | 36330763 |
|
Enhancer Sequence | CAGAATTTAC CTGAAAATTC ACTCAAAAAA GTCTCTCATT TGAAAGATGA ACTGGTAGAG 60 AATTGTGAAC ATACAGAACA AGGATATAAG TAGACAGAAC ACAGTCATTT TTTTGTTGAA 120 GTTGTTACTG TGAAATTTCA AGCTCCTTGG GTCTTCGAAA GGCCACTTTT ATGTCTGCAG 180 CTCCATAGAG ATACAACCAC TGAAATAAAA AACACAGTGA CTGGGCCATT TTGTTTACAC 240 AGTGCCACAT TCTTGGCCAG TCTTGTTTGT CACCAAATGG CCTGATGAAT GCTGTTTTGA 300 TGTCACGCCC TAGATACCAC TTTGTGTTTT TGTGCTCTTG GGCATGAATG GGTGACTAGC 360 TCACTCATGG GCTGTGGCTC TAAGGCCCCT GGTTACTGAG CAAAGTTGAT CTGAATTGCT 420 AGAACATTTG AGCCCATTTG CCCCATCCTG CTCGTTCTCC TCCTCTTCCT CTTTTTCTCT 480 CCCATATATA CAGTGATATG CAGGGCATAC CACTACATCA TAGATCTCAG TCCTCAAAGC 540 TTACAAAATT ACTTCCATTT GTGAGGTAAA CTAACTCTTG TTCCTCAGTC TTGAATTTAC 600 CCACCAGGCT TGCTGCAAAG AATGAGCTTA AAAATAACCT GATGATTTCC ACGTGGCAGG 660 GCCACGGGTT ACAGAGCACA GCCTGTGCCC CTAGGACAGG CACCCACATT GTTCTTTTTG 720 GAAGGAGTGG ATCTGATGCC AGGGAAAGGT GACACAAGAA AGAAGCTGGC CACGAAGCCT 780 CTGAGCTTTG TGACCTGATG CTCACCTGAC GCATGGCCAG GCTGTCTCCT CTCTGCCAAA 840 TAGGGAGAGA AACTCTGACT TGGCCGACAT CGTGGGTGTG TTAGGTAATA TTTGCCAACT 900 GCTTTGAAGA TGAAAAGCGT TATGGGGCAC TAAATGTGAT AATTATCAAT TATAAAACCT 960 CACTACTCCC TGGAACACTA GGGGCGAATG AGCAGGAAAT ATAAATGTTT GTGACAGGAA 1020 GCCAGGAGCC AGGATGGCTC GTGAAATGTG AAAAGTTCAA CACACAGTGC CCTTACCTGG 1080 GGCAAGCCAG GAACTCATTT GTCTTTGGAA GGTAAATGCT TCCTTGAGCT AACGAGGTGG 1140 CCCCCTGAGA GACTACCTTA TTAAGTACTC CTGGAATTCT GGGCAAGGGG TGCCTGTGTA 1200 CCTCTCCAGT GCCACCTGGG TGCCATGAAA AAAATGTCCC ACTTGGAGTT TGGCCTGGGC 1260 TTTTCCCTCA TCCTTTCTCT ATTATCCGAG GATAACAGGG TGATAGACTG AAGACCTCTG 1320 GGCCGTTCAG ATATTCGTAC ATTCTAGACA CACATCATGA TGATATTCAC ACATCATAAT 1380 CATTGAGCTT TTGCAAGGAT CCCGGAATGA GGCACACACC TCCTCTGGCC ATTTGATTGT 1440 GTTTATAAAC TGAAGTGTTC TTGTCTTGGA AATCTTTAGC CTTTTCAGGG TCATCTGGAA 1500 TCCCGAGGCT GATGTCATGT CCGGCTATCG GCACATGTAG TGTAGGCAGT TTACTCTATG 1560 GCTTCATCTG AGGGGTATGG GGCAGGATGT CTGTCCCAGT AGCCAACCCT TTTGCCCGTC 1620 AGGCCACCAA TGGGAATTTC TCTTGCCAGT GGTTTGTTTG TACAAGTCTC CCAACAAATG 1680 CATCCTTGTA AAGGATGGCG GTAAAATAAT AACTCCTTCT AGTTCATCTT TTTTGAAAGA 1740 CAGACAAATT TGGGGGCACT CAGAAGAATT ACAATTATTT ACCTCCTGTG AGATAAAGGG 1800 CTGTCTAACA GGCTGATGTG TGGCCAGGAC AAAACAGAGC AGAAACAGTG CCCATTACTG 1860 AGCAAGTAGA CAACACGGGA CTCCAAGTCT AGACACTGCC AGCGCCCAGC TGTGTGCTTA 1920 TGGCGAACCC CTTCCCCTCC CCTACAGAGG CTCAGTGAAC ATTCGTAAAA TGAAACCAGC 1980 CCAGCTAGGC AAATGATTTT AAGTCCTTCC TTGCTCTAAA GACTCAAACA 2030
|